If you have chronic obstructive pulmonary disease (COPD), your airways may be inflamed. It may be hard to take deep breaths and get enough oxygen.

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

Researchers have shown that activation of the protein YAP, which helps tumours grow, differs between two- and three-dimensional culture models, pointing to more predictive systems for testing cancer ...

It had been hoped that RA patients might actually benefit more from these drugs, known as immune checkpoint inhibitors (ICIs) ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung ...

Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with ...

Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.

A panelist discusses how the MARIPOSA, SKIPPirr, and COCOON studies highlight the significant overall survival benefit of the ...

Andrew Car, a patient from the United Kingdom, received treatment at Shanghai East Hospital for multiple lung cancer nodules using the world-pioneering "Shanghai solution", pleuroscopy-assisted early ...

Children's Day on May 5th is also 'World Pulmonary Hypertension Day'. Pulmonic Hypertension (PH) is a disease in which ...

The American Association for Cancer Research’s annual conference continued Monday with Roche offering a postmortem for its ...